Ontology highlight
ABSTRACT:
SUBMITTER: Kim SY
PROVIDER: S-EPMC5746397 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature
Kim Sun-Yong SY Kim Hyo Jeong HJ Byeon Hyung Kwon HK Kim Dae Ho DH Kim Chul-Ho CH
Oncotarget 20171130 66
AKT (also known as protein kinase B, PKB) plays an important role in cell survival or tumor progression. For these reasons, AKT is an emerging target for cancer therapeutics. Previously our studies showed that mitochondrial E3 ubiquitin protein ligase 1 (MUL1, also known as MULAN/GIDE/MAPL) is suppressed in head and neck cancer (HNC) and acts as negative regulator against AKT. However, the MUL1 regulatory mechanisms remain largely unknown. Here we report that cisplatin (CDDP) induces thyroid can ...[more]